Clinical trials
Diagnosis clinical trials
Below are recruiting diagnosis clinical trials, each written for real people, not researchers. We’re tracking 928 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07467109Recruiting
Blood test from brain veins for brain cancer diagnosis
This study is testing a new way to collect a blood sample from the veins in your brain to look for signs of a type of brain tumor called high-grade glioma. It may help doctors find and understand these tumors better without always needing surgery.
Houston, TexasAges 18 years+ - NCT07469657Recruiting
Cost-effectiveness of a non-invasive prenatal test for genetic disorders
This study is testing a non-invasive prenatal blood test (NIPD) that can check for certain serious genetic disorders in your baby, instead of using more invasive methods like amniocentesis. If you are at risk of passing on a severe genetic condition, this test may help you get answers safely.
Paris, Île-de-France RegionAges 18 years+ - NCT07466056Recruiting
Wearable heart monitor test for hospital patients
This trial tests a new, soft, wearable monitor that tracks your heart and body signs without wires or sticky pads. It aims to see if this device can help doctors diagnose and treat heart disease more comfortably.
Beijing, ChinaAges 18–85 - NCT06775977Recruiting
Ultrasound contrast for bladder cancer staging
This trial uses a special ultrasound with contrast dye to get a clearer picture of bladder cancer before any treatment. It aims to improve how doctors determine the stage of the cancer, which helps guide the best treatment plan.
Guangzhou, GuangdongAges 18–75 - NCT06793020Recruiting
Study of sepsis-related heart damage using a math model
This trial tests a new mathematical model to better diagnose and treat heart problems caused by sepsis. It includes adults with sepsis or septic shock who need strong blood pressure support.
VilniusAges 18 years+ - NCT07457502Recruiting
Home environment and lung disease progression study
This study looks at whether things in your home might affect how quickly your lung disease gets worse. You and a matched group will be followed to see how your home environment impacts your lung health.
Paris, ParisAges 18 years+ - NCT07454603Recruiting
Blood test for prostate cancer risk
This trial tests a new blood test to help decide if you need a prostate biopsy. It may help men with high PSA levels or an abnormal rectal exam avoid unnecessary procedures.
Branford, ConnecticutAges 45–80 - NCT07455396RecruitingPhase 2
Dexamethasone vs methylprednisolone for children with severe asthma
This trial compares two steroids, dexamethasone and methylprednisolone, to see which works better for children in the intensive care unit with severe asthma. The goal is to find the best treatment with fewer side effects.
St. Petersburg, FloridaAges 3–17 - NCT07455942Recruiting
Understanding why anal cancer diagnosis is delayed
This study looks at the reasons and delays in diagnosing anal cancer. It aims to help doctors detect it earlier in the future.
AngersAges 18 years+ - NCT06305468Recruiting
Toxoplasmosis prognosis in ICU patients diagnosed by PCR
This study looks at how people with severe toxoplasmosis (a parasitic infection) that affects the brain or spreads in the body, and who need intensive care, recover. It uses a sensitive test called PCR to confirm the infection.
Paris, FranceAges 18–100 - NCT06795711Recruiting
Testing ultrasound for better adenomyosis diagnosis
This study tests whether ultrasound can more accurately diagnose adenomyosis, a condition where the inner lining of the uterus grows into the muscle wall. It may help you get a clearer diagnosis without more invasive tests.
Bologna, BolognaAges 18–60 - NCT07446842Recruiting
AI model for better diagnosis of brain diseases
This study is building an artificial intelligence system to improve how doctors diagnose brain conditions using scans like MRI. If you are diagnosed with one of the listed conditions, your scans and medical information may help train the AI.
Wuhan, HubeiAges Any age - NCT07451912RecruitingPhase 1/Phase 2
Venetoclax Combo for CEBPA-Mutated AML in Unfit Patients
This trial tests a combination of three drugs (venetoclax, a hypomethylating agent, and low-dose cytarabine) for people with newly diagnosed AML that has a CEBPA gene mutation and who are not strong enough for standard intensive chemotherapy. The goal is to see if this gentler approach works well.
Suzhou, JiangsuAges 18 years+ - NCT07448779Recruiting
A study on N-glycosylation and its role in AL amyloidosis
This research study looks at how certain sugar molecules (N-glycosylation) on proteins may play a role in a disease called AL amyloidosis. Researchers will study blood samples from people with related plasma cell disorders to learn more about these sugars, which could help with diagnosis and treatment.
Pavia, PVAges 18–99 - NCT07452380Recruiting
Dust mite allergy shot therapy for kids with rhinitis or asthma
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
Hangzhou, ZhejiangAges 5–18 - NCT07453186Recruiting
Ultrasound scans before weight loss surgery
This trial tests if two types of ultrasound scans can help see the gallbladder and liver better in people scheduled for weight loss surgery. It may lead to safer procedures.
EsbjergAges 18 years+ - NCT07448233Enrolling by invitation
AI health management for epilepsy in rural areas
This trial tests a smartphone-based AI system to help manage epilepsy long-term in rural areas. It is for people who have had at least one convulsive seizure in the past year and can use a smartphone with a caregiver.
Xi'an, ShaanxiAges 18–65 - NCT06801262Recruiting
New Blood Test to Detect Kidney Transplant Rejection
This trial is testing a new blood test (called TreaT-Assay) to help diagnose acute rejection after a kidney transplant. The goal is to catch rejection earlier and more accurately, so you can get the right treatment faster.
BolognaAges 18 years+ - NCT04174157Recruiting
Spinal muscular atrophy patient registry for OAV-101
This is a registry that collects information from people with spinal muscular atrophy (SMA) who have been treated with OAV-101. It helps researchers understand how patients do over time after this treatment.
Phoenix, ArizonaAges Any age - NCT06802731Recruiting
Testing a tool to measure liver inflammation in NAFLD
This trial studies a device called LivQ-box to see if it can accurately measure liver inflammation in people with nonalcoholic fatty liver disease (NAFLD). It compares the device's results to a liver biopsy.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06804421Recruiting
Treating stroke-like symptoms after brain bleed
This trial is for people who had a brain bleed from a burst aneurysm and need intensive care. It tests better ways to diagnose and treat delayed brain injury that can happen days or weeks later.
Bergamo, BGAges 18 years+ - NCT06804278Recruiting
Spectral CT for diagnosing heart inflammation in chest pain
This study uses a special CT scan (called spectral CT) to look for inflammation of the heart muscle or other heart problems in people who come to the hospital with sudden chest pain. The goal is to see if this scan can help doctors diagnose the cause of your chest pain more accurately.
BolognaAges 18 years+ - NCT06807307Recruiting
Using genetic tests to predict immunotherapy response in lung cancer
This study looks at genetic material from tumor samples to find patterns that can predict whether immunotherapy will work for people with advanced non-small cell lung cancer (NSCLC). The goal is to improve how doctors choose treatments for each patient.
RomeAges 18 years+ - NCT06806605Recruiting
3D computer planning for jaw surgery
This trial tests whether a full 3D computer-assisted approach helps better diagnose and correct jaw and facial deformities during orthognathic surgery. It may benefit patients who need surgery to realign their jaws.
Bologna, Emilia-RomagnaAges 18–60
Hear when a new Diagnosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diagnosis?
- Yes. Clin2 currently lists 928 recruiting diagnosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diagnosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diagnosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.